Nantbioscience, Inc.
Records under this name other than the patents Nantbioscience, Inc. holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned. None of them is counted in the 10 patents it holds.
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 9,687,491 | Compositions and Methods of Targeting Mutant K-Ras Formerly held In force · High confidence | In force | High confidence | |
| US 10,668,076 | Compositions and Methods of Targeting Mutant K-Ras Formerly held In force · High confidence | In force | High confidence | |
| US 9,458,137 | Substituted indol-5-ol derivatives and their therapeutical applications Formerly held In force · From the USPTO record | In force | From the USPTO record | |
| US 10,160,749 | Substituted indol-5-ol derivatives and their therapeutical applications Formerly held In force · From the USPTO record | In force | From the USPTO record | |
| US 10,183,013 | Cyclic Sulfonamide Containing Derivatives as Inhibitors of Hedgehog Signaling Pathway Formerly held In force · Medium confidence | In force | Medium confidence | |
| US 9,550,760 | Substituted INDOL-5-OL Derivatives and Their Therapeutic Applications Formerly held In force · High confidence | In force | High confidence | |
| US 10,245,261 | Substituted INDOL-5-OL Derivatives and Their Therapeutic Applications Formerly held In force · Medium confidence | In force | Medium confidence | |
| US 11,011,273 | Pathway analysis for identification of diagnostic tests Formerly held In force · From the USPTO record | In force | From the USPTO record | |
| US 10,724,043 | Multi-pulse transfection methods and cells Formerly held In force · From the USPTO record | In force | From the USPTO record | |
| US 11,939,585 | Multi-pulse transfection methods and cells Formerly held In force · From the USPTO record | In force | From the USPTO record |